Literature DB >> 26909198

Unusual Presentation of Dengue Fever: A child with acute myocarditis.

Moaz Aslam1, Numra A Aleem1, Mohammad F Zahid1, Arshalooz J Rahman2.   

Abstract

Dengue fever (DF) is an acute febrile illness that follows a self-limiting course. However, some patients suffer from complications, including myocarditis, due to the involvement of other organs. A child presented at the Aga Khan University Hospital in Karachi, Pakistan, in June 2013 with a high-grade fever, malaise and epigastric pain radiating to the chest. Positive DF antigen and immunoglobulin M assays confirmed the diagnosis of DF. Persistent bradycardia with low blood pressure led to further cardiac investigations which showed a decreased ejection fraction and raised serum cardiac enzymes, indicating myocardial damage. With supportive care and use of inotropes, the spontaneous normalisation of cardiac enzyme levels and ejection fraction was observed. The child was discharged five days after admission. This case highlights the importance of identifying myocarditis in DF patients suffering from cardiac symptoms that are not explained by other potential aetiologies. Awareness, early suspicion and supportive care are essential to ensure favourable outcomes.

Entities:  

Keywords:  Case Report; Child; Complications; Dengue Fever; Myocarditis; Pakistan

Year:  2016        PMID: 26909198      PMCID: PMC4746028          DOI: 10.18295/squmj.2016.16.01.019

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  20 in total

1.  Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005.

Authors:  S A M Kularatne; M M K Pathirage; P V R Kumarasiri; S Gunasena; S I Mahindawanse
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-04-10       Impact factor: 2.184

2.  Morbitz type I second degree AV block during recovery from dengue hemorrhagic fever.

Authors:  A Khongphatthallayothin; P Chotivitayatarakorn; S Somchit; A Mitprasart; S Sakolsattayadorn; C Thisyakorn
Journal:  Southeast Asian J Trop Med Public Health       Date:  2000-12       Impact factor: 0.267

3.  Cardiac involvement in Dengue Haemorrhagic Fever.

Authors:  J P Wali; A Biswas; S Chandra; A Malhotra; P Aggarwal; R Handa; N Wig; V K Bahl
Journal:  Int J Cardiol       Date:  1998-03-13       Impact factor: 4.164

4.  Dengue haemorrhagic fever in children in the 1996 Delhi epidemic.

Authors:  S K Kabra; Y Jain; R M Pandey; T Singhal; P Tripathi; S Broor; P Seth; V Seth
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 May-Jun       Impact factor: 2.184

Review 5.  Dengue infections during pregnancy: a case series from Sri Lanka and review of the literature.

Authors:  Ranmali Waduge; G N Malavige; M Pradeepan; Chandrika N Wijeyaratne; Sirimali Fernando; Suranjith L Seneviratne
Journal:  J Clin Virol       Date:  2006-07-13       Impact factor: 3.168

6.  The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy.

Authors:  M A G M Olimulder; J van Es; M A Galjee
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

7.  Fulminant dengue myocarditis masquerading as acute myocardial infarction.

Authors:  Chi-Hang Lee; Clarence Teo; Adrian F Low
Journal:  Int J Cardiol       Date:  2008-08-13       Impact factor: 4.164

8.  A case presentation of a fatal dengue myocarditis showing evidence for dengue virus-induced lesion.

Authors:  Carlos Henrique Miranda; Marcos de Carvalho Borges; André Schmidt; Antônio Pazin-Filho; Marcos Antônio Rossi; Simone Gusmão Ramos; Benedito Antônio Lopes da Fonseca
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

Review 9.  Cardiovascular manifestations of the emerging dengue pandemic.

Authors:  Sophie Yacoub; Heiman Wertheim; Cameron P Simmons; Gavin Screaton; Bridget Wills
Journal:  Nat Rev Cardiol       Date:  2014-04-08       Impact factor: 32.419

10.  Epidemiology of dengue: past, present and future prospects.

Authors:  Natasha Evelyn Anne Murray; Mikkel B Quam; Annelies Wilder-Smith
Journal:  Clin Epidemiol       Date:  2013-08-20       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.